Published in Int J Radiat Oncol Biol Phys on December 01, 1996
Radiation medicine innovations for the new millenium. J Natl Med Assoc (2003) 0.83
Radiation therapy for the treatment of recurrent glioblastoma: an overview. Cancers (Basel) (2012) 0.83
Neuro-oncology: Therapeutic benefits of reirradiation for recurrent brain tumors. Nat Rev Neurol (2010) 0.82
Radiosurgery for high-grade glioma. Surg Neurol Int (2012) 0.81
Radiosurgery for glioma patients: hope or hype? Int J Radiat Oncol Biol Phys (1996) 0.81
A Review of the Role of Re-Irradiation in Recurrent High-Grade Glioma (HGG). Cancers (Basel) (2011) 0.79
Salvage radiosurgery for selected patients with recurrent malignant gliomas. Biomed Res Int (2014) 0.79
Stereotactic Radiosurgery for Glioblastoma. Cureus (2015) 0.78
Indications and Efficacy of Gamma Knife Stereotactic Radiosurgery for Recurrent Glioblastoma: 2 Decades of Institutional Experience. Neurosurgery (2016) 0.77
Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation. Eur Radiol (2016) 0.77
Factors predictive of improved overall survival following stereotactic radiosurgery for recurrent glioblastoma. Neurosurg Rev (2015) 0.77
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology (1994) 8.79
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys (2000) 5.06
Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys (1999) 4.72
Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology (1990) 4.41
Long-term outcomes after radiosurgery for acoustic neuromas. N Engl J Med (1998) 4.23
Production and auto-induction of transforming growth factor-alpha in human keratinocytes. Nature (1987) 4.19
A molecular basis for MHC class II--associated autoimmunity. Science (1988) 3.75
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma. Neurology (2009) 3.68
Trefoil peptides: less clandestine in the intestine. Science (1996) 3.60
Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci (2001) 3.51
Toward effective needle steering in brain tissue. Conf Proc IEEE Eng Med Biol Soc (2006) 3.38
A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys (1994) 3.29
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest (1997) 2.99
Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology (2000) 2.99
Performance of single-photon-counting PILATUS detector modules. J Synchrotron Radiat (2009) 2.97
Living alone after myocardial infarction. Impact on prognosis. JAMA (1992) 2.88
alpha-Catenin-vinculin interaction functions to organize the apical junctional complex in epithelial cells. J Cell Biol (1998) 2.74
Arctic and Antarctic exploration including the contributions of physicians and effects of disease in the polar regions. Neurosurgery (1999) 2.67
Meningeal hemangiopericytoma: histopathological features, treatment, and long-term follow-up of 44 cases. Neurosurgery (1989) 2.66
Overexpression of transforming growth factor alpha in psoriatic epidermis. Science (1989) 2.63
A randomized trial of nonoperative treatment for perforated peptic ulcer. N Engl J Med (1989) 2.63
Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. Cell (1990) 2.63
Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry (2008) 2.55
Radiation Therapy Oncology Group: radiosurgery quality assurance guidelines. Int J Radiat Oncol Biol Phys (1993) 2.55
Magnetic resonance imaging: an accurate method to evaluate arteriovenous malformations after stereotactic radiosurgery. J Neurosurg (1996) 2.55
Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst (1997) 2.52
Stereotactic radiosurgery for arteriovenous malformations of the brain. J Neurosurg (1991) 2.41
Clinical outcomes after stereotactic radiosurgery for idiopathic trigeminal neuralgia. J Neurosurg (2001) 2.36
Long-term outcomes after meningioma radiosurgery: physician and patient perspectives. J Neurosurg (1999) 2.35
Identification of human adenovirus early region 1 products by using antisera against synthetic peptides corresponding to the predicted carboxy termini. J Virol (1983) 2.35
Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys (1980) 2.33
Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPbeta. Nat Med (1997) 2.32
Death from a malignant cerebellopontine angle triton tumor despite stereotactic radiosurgery. Case report. J Neurosurg (1998) 2.31
Reduction of hemorrhage risk after stereotactic radiosurgery for cavernous malformations. J Neurosurg (1995) 2.26
The natural history of cerebral cavernous malformations. J Neurosurg (1995) 2.21
Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice. J Clin Invest (2000) 2.17
A new type of transforming growth factor-beta, TGF-beta 3. EMBO J (1988) 2.12
Digital incremental techniques applied to spirometry. Proc R Soc Med (1977) 2.10
Effects of exposure to slate dust in North Wales. Br J Ind Med (1980) 2.09
Regulation of intestinal epithelial cell growth by transforming growth factor type beta. Proc Natl Acad Sci U S A (1989) 2.09
Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc Natl Acad Sci U S A (2000) 2.08
Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Proc Natl Acad Sci U S A (1995) 2.07
Lung cancer complicating pregnancy: case report and review of literature. Mayo Clin Proc (1995) 2.06
Evidence for segregated pain and temperature conduction within the spinothalamic tract. J Neurosurg (1995) 2.03
Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci U S A (1988) 2.03
Radiosurgery patterns of practice. Surg Neurol (1995) 2.00
Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg (1994) 2.00
Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys (2001) 1.98
Treatment of spinal epidural metastases. Randomized prospective comparison of laminectomy and radiotherapy. J Neurosurg (1980) 1.97
Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J Clin Oncol (1995) 1.96
Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor. Proc Natl Acad Sci U S A (1999) 1.96
Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol Carcinog (1991) 1.95
Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg (1993) 1.94
Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. J Clin Oncol (1999) 1.89
Predicting verbal memory decline following anterior temporal lobectomy (ATL). Neurology (2003) 1.89
Expansion of Pdx1-expressing pancreatic epithelium and islet neogenesis in transgenic mice overexpressing transforming growth factor alpha. Gastroenterology (1999) 1.88
Hepatic processing of transforming growth factor beta in the rat. Uptake, metabolism, and biliary excretion. J Clin Invest (1987) 1.88
Surgical treatment of syringomyelia. Favorable results with syringoperitoneal shunting. J Neurosurg (1984) 1.84
Purification, identification, and characterization of an osmotic response element binding protein. Biochem Biophys Res Commun (2000) 1.84
An integrated functional magnetic resonance imaging procedure for preoperative mapping of cortical areas associated with tactile, motor, language, and visual functions. Neurosurgery (2000) 1.83
Identification and characterization of a novel human aldose reductase-like gene. J Biol Chem (1998) 1.82
Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys (1993) 1.79
Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg (1991) 1.78
Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc Natl Acad Sci U S A (1991) 1.77
Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J (1999) 1.76
Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2. Mol Cell Biol (1989) 1.76
Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology (1995) 1.74
Production of transforming growth factors by human colon cancer lines. Cancer Res (1986) 1.74
Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. AJNR Am J Neuroradiol (2001) 1.73
Subdural tension pneumocephalus. Report of two cases. J Neurosurg (1979) 1.73
Osteoconduction at porous hydroxyapatite with various pore configurations. Biomaterials (2000) 1.71
Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1998) 1.71
Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int J Radiat Oncol Biol Phys (1994) 1.70
A dose-response analysis of arteriovenous malformation obliteration after radiosurgery. Int J Radiat Oncol Biol Phys (1996) 1.70
Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal. J Clin Invest (1989) 1.69
Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J Cell Physiol (1987) 1.68
Transforming growth factors and control of neoplastic cell growth. J Cell Biochem (1987) 1.67
Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery (1998) 1.66
Stereotactic radiosurgery for brain metastasis from renal cell carcinoma. Cancer (1998) 1.64